11.11.2014 Views

Pleading Standards in Mass Tort Cases After Iqbal - Dinsmore ...

Pleading Standards in Mass Tort Cases After Iqbal - Dinsmore ...

Pleading Standards in Mass Tort Cases After Iqbal - Dinsmore ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Product Liability<br />

<strong>Mass</strong> <strong>Tort</strong>s and Class Actions<br />

<strong>in</strong> a Post-<strong>Iqbal</strong> World<br />

S<strong>in</strong>ce <strong>Iqbal</strong> came down, it has been cited<br />

thousands of times and has been the subject<br />

of commentary both <strong>in</strong> pr<strong>in</strong>t and<br />

onl<strong>in</strong>e. Because a plead<strong>in</strong>g’s adequacy is<br />

measured by the federal rules regardless<br />

of where a case was orig<strong>in</strong>ally filed, <strong>Iqbal</strong>’s<br />

significance will be felt <strong>in</strong> cases orig<strong>in</strong>ally<br />

filed <strong>in</strong> federal court and <strong>in</strong> cases removed<br />

from state court. See Hanna v. Plumer, 380<br />

U.S. 460 (1965); Hayduk v. Lanna, 775 F.2d<br />

441, 443 (1st Cir. 1985). This section will<br />

discuss cases apply<strong>in</strong>g <strong>Iqbal</strong> <strong>in</strong> the mass<br />

torts and class action context.<br />

A number of courts have already relied<br />

on <strong>Iqbal</strong> to support dismiss<strong>in</strong>g compla<strong>in</strong>ts<br />

under Rule 12(b)(6), and understand<strong>in</strong>g<br />

the sort of allegations now deemed <strong>in</strong>sufficient<br />

will help <strong>in</strong> assess<strong>in</strong>g whether to seek<br />

dismissal <strong>in</strong> a particular case. For example,<br />

<strong>in</strong> S<strong>in</strong>altra<strong>in</strong>al v. Coca-Cola Co., 578 F.3d<br />

1252, 1257 (11th Cir. 2009), the Eleventh<br />

Circuit reversed a denied dismissal motion<br />

<strong>in</strong> a case <strong>in</strong> which the defendants, employers<br />

who allegedly collaborated with Colombian<br />

paramilitary forces to murder and<br />

torture the pla<strong>in</strong>tiffs, trade union leaders.<br />

The pla<strong>in</strong>tiffs’ allegations that the paramilitary<br />

forces had acted as arms of the state<br />

had been essential to their claim. In hold<strong>in</strong>g<br />

that these allegations had been <strong>in</strong>sufficiently<br />

substantiated <strong>in</strong> the <strong>in</strong>itial plead<strong>in</strong>g,<br />

the Court stated:<br />

[P]la<strong>in</strong>tiffs allege the paramilitary are<br />

“permitted to exist” and are “assisted”<br />

by the Colombian government. Additionally,<br />

the pla<strong>in</strong>tiffs allege “[i]t is universally<br />

acknowledged that the regular<br />

military and the civil government authorities<br />

<strong>in</strong> Colombia tolerate the paramilitaries,<br />

allow them to operate, and<br />

often cooperate, protect and/or work<br />

<strong>in</strong> concert with them.” These pla<strong>in</strong>tiffs<br />

also contend the paramilitaries are state<br />

actors who had a symbiotic relationship<br />

with the Colombian military and<br />

thus operated under color of law. The<br />

pla<strong>in</strong>tiffs’ conclusory allegation that the<br />

paramilitary security forces acted under<br />

color of law is not entitled to be assumed<br />

true and is <strong>in</strong>sufficient to allege statesponsored<br />

action. See <strong>Iqbal</strong>, 129 S. Ct. at<br />

1951. Colombia’s mere “registration and<br />

toleration of private security forces does<br />

not transform those forces’ acts <strong>in</strong>to state<br />

70 n For The Defense n December 2009<br />

acts.” Allegations the Colombian government<br />

tolerated and permitted the paramilitary<br />

forces to exist are <strong>in</strong>sufficient<br />

to plead the paramilitary forces were<br />

state actors. The pla<strong>in</strong>tiffs make the naked<br />

allegation the paramilitaries were<br />

<strong>in</strong> a symbiotic relationship with the Colombian<br />

government and thus were state<br />

actors. Nevertheless, <strong>in</strong> test<strong>in</strong>g the sufficiency<br />

of the pla<strong>in</strong>tiff’s allegations, we<br />

do not credit such conclusory allegations<br />

as true. See <strong>Iqbal</strong>, 129 S. Ct. at 1951. We<br />

demand allegations of a symbiotic relationship<br />

that “<strong>in</strong>volves the torture or kill<strong>in</strong>g<br />

alleged <strong>in</strong> the compla<strong>in</strong>t to satisfy the<br />

requirement of state action.” There is no<br />

suggestion the Colombian government<br />

was <strong>in</strong>volved <strong>in</strong>, much less aware of, the<br />

murder and torture alleged <strong>in</strong> the compla<strong>in</strong>ts.<br />

The pla<strong>in</strong>tiffs’’ “formulaic recitation,”<br />

Twombly, 550 U.S. at 555, 127 S.<br />

Ct. at 1965, that the paramilitary forces<br />

were <strong>in</strong> a symbiotic relationship and<br />

were assisted by the Colombian government,<br />

absent any factual allegations to<br />

support this legal conclusion, is <strong>in</strong>sufficient<br />

to state to support an allegation of<br />

state action that is plausible on its face.<br />

See <strong>Iqbal</strong>, 129 S. Ct. at 1950.<br />

S<strong>in</strong>altra<strong>in</strong>al, 578 F.3d at 1266 (some <strong>in</strong>ternal<br />

citations omitted).<br />

In Pa. Emples. Benefit Trust Fund v.<br />

Astrazeneca Pharms. LP, 2009 U.S. Dist.<br />

LEXIS 76555 (M.D. Fla. 2009), the pla<strong>in</strong>tiff<br />

had provided health <strong>in</strong>surance and prescription<br />

drug coverage to employees of the<br />

Commonwealth of Pennsylvania. Alleg<strong>in</strong>g<br />

that the defendant, a pharmaceutical<br />

manufacturer, improperly promoted and<br />

marketed Seroquel, the pla<strong>in</strong>tiff sought to<br />

recoup funds it had expended on behalf<br />

of members who had been prescribed the<br />

medic<strong>in</strong>e. In address<strong>in</strong>g the sufficiency<br />

of the compla<strong>in</strong>t’s allegations of breach of<br />

warranty, the Court stated:<br />

As to any direct communication of<br />

express warranties from Defendant to<br />

Pla<strong>in</strong>tiff, Defendant po<strong>in</strong>ts out that the<br />

compla<strong>in</strong>t is devoid of facts support<strong>in</strong>g<br />

even an <strong>in</strong>ference that the terms of any<br />

alleged warranties were received by Pla<strong>in</strong>tiff<br />

directly from the company. Pla<strong>in</strong>tiff<br />

counters by referr<strong>in</strong>g to four paragraphs<br />

<strong>in</strong> the compla<strong>in</strong>t conta<strong>in</strong><strong>in</strong>g allegations<br />

that AstraZeneca conveyed its alleged<br />

warranties “[t]hrough its label<strong>in</strong>g, as<br />

well as its sales and market<strong>in</strong>g practices<br />

and documents given or shown to physicians<br />

treat<strong>in</strong>g PEBTF participants and/<br />

or the PEBTF itself….” Notably, however,<br />

the allegations of direct communication<br />

are entirely unsupported by<br />

facts conta<strong>in</strong>ed elsewhere <strong>in</strong> the compla<strong>in</strong>t.<br />

As the Supreme Court of the<br />

United States recently clarified, a federal<br />

compla<strong>in</strong>t does not “suffice if it tenders<br />

‘naked asser tion[s]’ devoid of ‘further<br />

factual enhancement.’” <strong>Iqbal</strong>, 129 S. Ct.<br />

at 1949.Furthermore, even Pla<strong>in</strong>tiff’s<br />

“naked assertions” of direct contact with<br />

Defendant are vaguely stated; Pla<strong>in</strong>tiff<br />

<strong>in</strong>dicates that AstraZeneca’s market<strong>in</strong>g<br />

materials and Seroquel label<strong>in</strong>g were<br />

“given or shown to physicians treat<strong>in</strong>g<br />

PEBTF participants and/or PEBTF<br />

itself.” Such equivocal allegations suggest<br />

that PEBTF itself is unsure whether<br />

it received any direct market<strong>in</strong>g <strong>in</strong>formation<br />

from AstraZeneca regard<strong>in</strong>g uses<br />

of Seroquel that were unapproved by the<br />

FDA. Indeed, a close read<strong>in</strong>g of the compla<strong>in</strong>t<br />

strongly suggests that AstraZeneca’s<br />

alleged warranties reached PEBTF<br />

only by way of a treat<strong>in</strong>g physician’s prescription<br />

pad, if at all. See Doc. 3 at 31<br />

(“Pennsylvania physicians who treat,<br />

and prescribe medications for, PEBTF<br />

participants necessarily act as the <strong>in</strong>termediary<br />

between Defendant and the<br />

Pla<strong>in</strong>tiff.”); id. at 6 (“The PEBTF and its<br />

PBM [“phar macy benefit manager”] rely<br />

on persons caus<strong>in</strong>g claims to be submitted<br />

for payment by the Pla<strong>in</strong>tiff to recognize<br />

and honor the permissible scope<br />

of reimbursement and to obey the govern<strong>in</strong>g<br />

law and regulations <strong>in</strong> activities<br />

that cause such claims.”); id. at 32<br />

(“Defendant breached the express warranties<br />

it made to the PEBTF, through<br />

physicians participat<strong>in</strong>g <strong>in</strong> PEBTF….”)<br />

(emphasis added). In sum, the Court<br />

need not credit Pla<strong>in</strong>tiff’s bald allegations<br />

of any direct communication of<br />

express warranties from Defendant for<br />

purposes of the motion to dismiss.<br />

Pa. Emples. Benefit Trust Fund, 2009 U.S.<br />

Dist. LEXIS 76555, at *8–10. Note the difference<br />

between this hold<strong>in</strong>g and that of<br />

the magistrate judge’s pre-<strong>Iqbal</strong> decision <strong>in</strong><br />

Peters v. Amoco.<br />

Of course, not everyth<strong>in</strong>g has come<br />

up roses for defendants <strong>in</strong> the post-<strong>Iqbal</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!